{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:34:23Z","timestamp":1790346863630,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK122364"],"award-info":[{"award-number":["R01DK122364"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peter and Marsha Carlino Early Career Professorship in Inflammatory Bowel Disease"},{"name":"Margot E. Walrath Career Development Professorship in Gastroenterology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several symptoms have been connected to increased healthcare resource utilization (HRU) in the context of inflammatory bowel disease (IBD), including both Crohn\u2019s disease (CD) and ulcerative colitis (UC). This study was designed to investigate the prevalence of IBD-associated symptoms and to determine whether any are independently associated with HRU. We undertook a retrospective analysis of data related to consecutive IBD patient encounters from a tertiary care referral center between 1\/1\/2015 and 8\/31\/2019. Demographics, clinical activity, endoscopic severity, IBD-related symptom scores, anxiety and depression scores, and other key clinical data were abstracted. Four hundred sixty-seven IBD patients [247f.: 220\u00a0m; 315 CD, 142 UC and 11 indeterminate colitis] were included in this study. The most common symptoms were fatigue (83.6%), fecal urgency (68.2%) and abdominal pain (63.5%). Fatigue, abdominal pain, anxiety or depression, corticosteroids, and opioids were each positively associated with HRU, while NSAID and mesalamine use were inversely associated on bivariate analysis. The only factor that demonstrated a statistically significant association with HRU in the whole cohort on multivariable analysis was abdominal pain. Abdominal pain is independently associated with HRU and should be specifically screened for in IBD patients to identify individuals at risk of undergoing expensive interventions. This study also reinforces the importance of optimizing diagnostic and therapeutic management of abdominal pain in IBD.<\/jats:p>","DOI":"10.1038\/s41598-022-14838-y","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T18:03:01Z","timestamp":1655920981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease"],"prefix":"10.1038","volume":"12","author":[{"given":"Kaleb","family":"Bogale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Maheshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Subhash","family":"Gorrepati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Dalessio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vonn","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"August","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Koltun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Bernasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tinsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"key":"14838_CR1","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2017","unstructured":"Ng, S. C. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet 390, 2769\u20132778 (2017).","journal-title":"Lancet"},{"key":"14838_CR2","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","volume":"65","author":"JM Dahlhamer","year":"2016","unstructured":"Dahlhamer, J. M., Zammitti, E. P., Ward, B. W., Wheaton, A. G. & Croft, J. B. Prevalence of inflammatory bowel disease among adults aged \u226518 years - United States, 2015. MMWR Morb. Mortal. Wkly Rep. 65, 1166\u20131169 (2016).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"14838_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park, K. T. et al. The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & colitis foundation. Inflamm. Bowel Dis. 26, 1\u201310 (2020).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.5114\/aoms.2016.59254","volume":"12","author":"P Kawalec","year":"2016","unstructured":"Kawalec, P. Indirect costs of inflammatory bowel diseases: Crohn\u2019s disease and ulcerative colitis A systematic review. Arch. Med. Sci. 12, 295\u2013302 (2016).","journal-title":"Arch. Med. Sci."},{"key":"14838_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ibd.21371","volume":"17","author":"MD Kappelman","year":"2011","unstructured":"Kappelman, M. D. et al. Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease. Inflamm. Bowel Dis. 17, 62\u201368 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/ecco-jcc\/jjz003","volume":"13","author":"N Pillai","year":"2019","unstructured":"Pillai, N. et al. The evolution of health care utilisation and costs for inflammatory bowel disease over ten years. J. Crohns Colitis. 13, 744\u2013754 (2019).","journal-title":"J. Crohns Colitis."},{"key":"14838_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1136\/gutjnl-2012-303376","volume":"63","author":"ME van der Valk","year":"2014","unstructured":"van der Valk, M. E. et al. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF\u03b1 therapy: results from the COIN study. Gut 63, 72\u201379 (2014).","journal-title":"Gut"},{"key":"14838_CR8","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","volume":"135","author":"MD Kappelman","year":"2008","unstructured":"Kappelman, M. D. et al. Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults. Gastroenterology 135, 1907\u20131913 (2008).","journal-title":"Gastroenterology"},{"key":"14838_CR9","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1097\/MIB.0000000000000139","volume":"20","author":"WK van Deen","year":"2014","unstructured":"van Deen, W. K. et al. A nationwide 2010\u20132012 analysis of U.S. health care utilization in inflammatory bowel diseases. Inflamm. Bowel Dis. 20, 1747\u20131753 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR10","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1097\/MIB.0000000000000763","volume":"22","author":"B Click","year":"2016","unstructured":"Click, B. et al. Demographic and clinical predictors of high healthcare use in patients with inflammatory bowel disease. Inflamm. Bowel Dis. 22, 1442\u20131449 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10620-020-06329-9","volume":"66","author":"W Cai","year":"2021","unstructured":"Cai, W., Cagan, A., He, Z. & Ananthakrishnan, A. N. A phenome-wide analysis of healthcare costs associated with inflammatory bowel diseases. Dig. Dis. Sci. 66, 760\u2013767 (2021).","journal-title":"Dig. Dis. Sci."},{"key":"14838_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/00042737-199809000-00010","volume":"10","author":"AG de Boer","year":"1998","unstructured":"de Boer, A. G., Sprangers, M. A., Bartelsman, J. F. & de Haes, H. C. Predictors of health care utilization in patients with inflammatory bowel disease: a longitudinal study. Eur. J. Gastroenterol. Hepatol. 10, 783\u2013789 (1998).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"14838_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10620-016-4414-9","volume":"62","author":"MC Tan","year":"2017","unstructured":"Tan, M. C., El-Serag, H. B. & Hou, J. K. Determinants of healthcare utilization among veterans with inflammatory bowel disease. Dig. Dis. Sci. 62, 607\u2013614 (2017).","journal-title":"Dig. Dis. Sci."},{"key":"14838_CR14","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1093\/ibd\/izz060","volume":"25","author":"JE Axelrad","year":"2019","unstructured":"Axelrad, J. E. et al. Increased healthcare utilization by patients with inflammatory bowel disease covered by medicaid at a tertiary care center. Inflamm. Bowel Dis. 25, 1711\u20131717 (2019).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cgh.2016.09.012","volume":"15","author":"J Limsrivilai","year":"2017","unstructured":"Limsrivilai, J. et al. Factors that predict high health care utilization and costs for patients with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 15, 385-392e382 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"14838_CR16","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/MPG.0000000000001207","volume":"63","author":"D Keerthy","year":"2016","unstructured":"Keerthy, D. et al. Effect of psychotherapy on health care utilization in children with inflammatory bowel disease and depression. J. Pediatr. Gastroenterol. Nutr. 63, 658\u2013664 (2016).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"14838_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cgh.2011.05.016","volume":"9","author":"S Singh","year":"2011","unstructured":"Singh, S. et al. Common symptoms and stressors among individuals with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol. 9, 769\u2013775 (2011).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"14838_CR18","first-page":"45","volume":"33","author":"MD Coates","year":"2020","unstructured":"Coates, M. D. et al. Gastrointestinal hypoalgesia in inflammatory bowel disease. Ann. Gastroenterol. 33, 45\u201352 (2020).","journal-title":"Ann. Gastroenterol."},{"key":"14838_CR19","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein, C. N., Blanchard, J. F., Rawsthorne, P. & Yu, N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am. J. Gastroenterol. 96, 1116\u20131122 (2001).","journal-title":"Am. J. Gastroenterol."},{"key":"14838_CR20","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1097\/MIB.0b013e31829614c6","volume":"19","author":"MD Coates","year":"2013","unstructured":"Coates, M. D. et al. Abdominal pain in ulcerative colitis. Inflamm. Bowel Dis. 19, 2207\u20132214 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR21","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","volume":"156","author":"AF Peery","year":"2019","unstructured":"Peery, A. F. et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology 156, 254-272.e211 (2019).","journal-title":"Gastroenterology"},{"key":"14838_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey, R. F. & Bradshaw, J. M. A simple index of Crohn\u2019s-disease activity. Lancet 1, 514 (1980).","journal-title":"Lancet"},{"key":"14838_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/gut.43.1.29","volume":"43","author":"RS Walmsley","year":"1998","unstructured":"Walmsley, R. S., Ayres, R. C., Pounder, R. E. & Allan, R. N. A simple clinical colitis activity index. Gut 43, 29\u201332 (1998).","journal-title":"Gut"},{"key":"14838_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiatr. Scand."},{"key":"14838_CR25","first-page":"1571","volume":"91","author":"EJ Irvine","year":"1996","unstructured":"Irvine, E. J., Zhou, Q. & Thompson, A. K. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn\u2019s Relapse Prevention Trial. Am. J. Gastroenterol. 91, 1571\u20131578 (1996).","journal-title":"Am. J. Gastroenterol."},{"key":"14838_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/1319-3767.182455","volume":"22","author":"E Koutroumpakis","year":"2016","unstructured":"Koutroumpakis, E. & Katsanos, K. H. Implementation of the simple endoscopic activity score in crohn\u2019s disease. Saudi J. Gastroenterol. 22, 183\u2013191 (2016).","journal-title":"Saudi J. Gastroenterol."},{"key":"14838_CR27","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/j.cgh.2020.01.023","volume":"18","author":"C Ma","year":"2020","unstructured":"Ma, C. et al. Assessing national trends and disparities in ambulatory, emergency department, and inpatient visits for inflammatory bowel disease in the United States (2005\u20132016). Clin. Gastroenterol. Hepatol. 18, 2500-2509.e2501 (2020).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"14838_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/ajg.2009.580","volume":"105","author":"AN Ananthakrishnan","year":"2010","unstructured":"Ananthakrishnan, A. N., McGinley, E. L., Saeian, K. & Binion, D. G. Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States: 1994\u20132005. Am. J. Gastroenterol. 105, 363\u2013370 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"14838_CR29","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cgh.2007.01.015","volume":"5","author":"M Bewtra","year":"2007","unstructured":"Bewtra, M., Su, C. & Lewis, J. D. Trends in hospitalization rates for inflammatory bowel disease in the United States. Clin. Gastroenterol. Hepatol. 5, 597\u2013601 (2007).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"14838_CR30","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/ibd.20250","volume":"13","author":"GC Nguyen","year":"2007","unstructured":"Nguyen, G. C., Tuskey, A., Dassopoulos, T., Harris, M. L. & Brant, S. R. Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004. Inflamm. Bowel Dis. 13, 1529\u20131535 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/apt.14551","volume":"47","author":"S Ballou","year":"2018","unstructured":"Ballou, S. et al. Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014. Aliment. Pharmacol. Ther. 47, 913\u2013921 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"14838_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10620-015-3895-2","volume":"61","author":"M Gajendran","year":"2016","unstructured":"Gajendran, M. et al. Analysis of hospital-based emergency department visits for inflammatory bowel disease in the USA. Dig. Dis. Sci. 61, 389\u2013399 (2016).","journal-title":"Dig. Dis. Sci."},{"key":"14838_CR33","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1007\/BF01296620","volume":"36","author":"DA Drossman","year":"1991","unstructured":"Drossman, D. A. et al. Health status and health care use in persons with inflammatory bowel disease: A national sample. Dig. Dis. Sci. 36, 1746\u20131755 (1991).","journal-title":"Dig. Dis. Sci."},{"key":"14838_CR34","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s10620-019-05968-x","volume":"65","author":"MD Coates","year":"2020","unstructured":"Coates, M. D. et al. Opioid analgesics do not improve abdominal pain or quality of life in crohn\u2019s disease. Dig Dis Sci. 65, 2379\u20132387 (2020).","journal-title":"Dig Dis Sci."},{"key":"14838_CR35","doi-asserted-by":"publisher","first-page":"G87","DOI":"10.1152\/ajpgi.00421.2014","volume":"309","author":"TK Lapointe","year":"2015","unstructured":"Lapointe, T. K. et al. TRPV1 sensitization mediates postinflammatory visceral pain following acute colitis. Am J Physiol Gastrointest Liver Physiol. 309, G87-99 (2015).","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"14838_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41575-018-0091-9","volume":"16","author":"NZ Borren","year":"2019","unstructured":"Borren, N. Z., van der Woude, C. J. & Ananthakrishnan, A. N. Fatigue in IBD: epidemiology, pathophysiology and management. Nat. Rev. Gastroenterol. Hepatol. 16, 247\u2013259 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"14838_CR37","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12325-019-01151-w","volume":"37","author":"A Nocerino","year":"2020","unstructured":"Nocerino, A. et al. Fatigue in inflammatory bowel diseases: etiologies and management. Adv. Ther. 37, 97\u2013112 (2020).","journal-title":"Adv. Ther."},{"key":"14838_CR38","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1136\/gut.2003.035758","volume":"53","author":"C Gasche","year":"2004","unstructured":"Gasche, C., Lomer, M. C., Cavill, I. & Weiss, G. Iron, anaemia, and inflammatory bowel diseases. Gut 53, 1190\u20131197 (2004).","journal-title":"Gut"},{"key":"14838_CR39","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1111\/j.1440-1746.2006.04820.x","volume":"22","author":"Z Ranjbaran","year":"2007","unstructured":"Ranjbaran, Z. et al. Impact of sleep disturbances in inflammatory bowel disease. J. Gastroenterol Hepatol. 22, 1748\u20131753 (2007).","journal-title":"J. Gastroenterol Hepatol."},{"key":"14838_CR40","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/ajg.2010.156","volume":"105","author":"J Keohane","year":"2010","unstructured":"Keohane, J. et al. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation?. Am. J. Gastroenterol. 105, 1789\u20131794 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"14838_CR41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ibd.20848","volume":"15","author":"K Bielefeldt","year":"2009","unstructured":"Bielefeldt, K., Davis, B. & Binion, D. G. Pain and inflammatory bowel disease. Inflamm. Bowel Dis. 15, 778\u2013788 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"14838_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156666","volume":"11","author":"J Zeitz","year":"2016","unstructured":"Zeitz, J. et al. Pain in IBD patients: Very frequent and frequently insufficiently taken into account. PLoS ONE 11, e0156666 (2016).","journal-title":"PLoS ONE"},{"key":"14838_CR43","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/ph3041084","volume":"3","author":"A Klein","year":"2010","unstructured":"Klein, A. & Eliakim, R. Non steroidal anti-inflammatory drugs and inflammatory bowel disease. Pharmaceuticals (Basel) 3, 1084\u20131092 (2010).","journal-title":"Pharmaceuticals (Basel)"},{"key":"14838_CR44","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","volume":"50","author":"MD Long","year":"2016","unstructured":"Long, M. D. et al. Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease. J. Clin. Gastroenterol. 50, 152\u2013156 (2016).","journal-title":"J. Clin. Gastroenterol."},{"key":"14838_CR45","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06590-y.)","author":"H Blaney","year":"2020","unstructured":"Blaney, H. et al. Anemia severity associated with increased healthcare utilization and costs in inflammatory bowel disease. Dig. Dis. Sci. https:\/\/doi.org\/10.1007\/s10620-020-06590-y.) (2020).","journal-title":"Dig. Dis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14838-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14838-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14838-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:49:40Z","timestamp":1669355380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14838-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14838"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14838-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,22]]},"assertion":[{"value":"24 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10577"}}